Volver a Agenda
Session Chair(s)
David A. Amato
Vice President, Biometrics and Data Management
Vertex Pharmaceuticals, United States
Learning Objective : Describe potential benefits of clinical trial simulation practices in the drug development process; Explain how clinical trial simulation can be used as an effective trial design and outcome prediction tool.
Speaker(s)
Experiences with Using Clinical Trial Simulation and Modeling at the Program Level
Nitin R. Patel, PHD, MBA
Cytel Inc., United States
Founder, Chairman and Chief Technology Officer
Simulation Guided Clinical Trial Design: Does It Improve the Final Design?
J. Kyle Wathen, PHD, MS
Cytel Inc., United States
Vice President, Scientific Strategy and Product Innovation
A Practical Perspective on Clinical Trial Simulations for the Treatment of Hepatitis C
Eric Haseltine, PHD
Vertex Pharmaceuticals, United States
Research Scientist
¿Tiene una cuenta?